220 related articles for article (PubMed ID: 14533935)
1. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
[TBL] [Abstract][Full Text] [Related]
3. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
4. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells.
Bakkelund K; Fossmark R; Nordrum I; Waldum H
J Histochem Cytochem; 2006 Jun; 54(6):615-21. PubMed ID: 16344325
[TBL] [Abstract][Full Text] [Related]
5. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
[TBL] [Abstract][Full Text] [Related]
6. Exocrine and endocrine modulation in common gastric carcinoma.
Canzonieri V; Colarossi C; Del Col L; Perin T; Talamini R; Sigon R; Cannizzaro R; Aiello E; Buonadonna A; Italia F; Massi D; Carbone A; Memeo L
Am J Clin Pathol; 2012 May; 137(5):712-21. PubMed ID: 22523208
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
12. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
15. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity.
Jiang SX; Mikami T; Umezawa A; Saegusa M; Kameya T; Okayasu I
Am J Surg Pathol; 2006 Aug; 30(8):945-53. PubMed ID: 16861964
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
17. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.
Lantuéjoul S; Laverrière MH; Sturm N; Moro D; Frey G; Brambilla C; Brambilla E
Hum Pathol; 2000 Apr; 31(4):415-21. PubMed ID: 10821486
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
20. Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma--a case report.
Jang KY; Moon WS; Lee H; Kim CY; Park HS
Pathol Res Pract; 2010 Jun; 206(6):387-90. PubMed ID: 19945227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
